Beckman Coulter has announced FDA clearance of its automated Access AMH immunoassay for in vitro diagnostic (IVD) use in the U.S.
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
Women diagnosed with restless leg syndrome had a 43% higher likelihood of death due to cardiovascular disease during a ten-year period, in new study.
Last year, the pharma industry’ biggest trade group raised millions to change the conversation about drug pricing.
Companion DX is one of at least six clinical labs mired in bankruptcy court after Medicare alleged they improperly billed the government for unnecessary tests.
Microscopes enhanced with AI could help clinical microbiologists diagnose potentially deadly blood infections and improve patients’ odds of survival.
The spread of some STI’s could potentially be dramatically reduced by instructing people to take antibiotics within 24 hours after unprotected sex.
Scientists have identified differences in a group of genes they say might help explain why some people need a lot more sleep, and others less, than most.
A new study indicates a benefit for all young colon cancer patients to have genetic testing.
Sanofi’s Admelog is the first meal-time insulin copy the FDA has approved.
The largest organisation of scientists who work in gene and cell therapy have come out against DIY gene therapies.
Understanding the precise mix of bacteria and their interactions could become a standard part of clinical practice in treating bacterial infections.
Researchers have identified an epigenetic transcription regulator that appears to influence the aggressiveness of pancreatic cancer cells